MGAT5 and neuroblastoma: As such, our current results support a past clinical NB study which showed that GnT-V, the enzyme which initiates β1,6-branchpoints, was of higher abundance in favorable stages (1, 2 and 4s) than unfavorable stages (3 and 4) of NB [26].